Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0000950170-24-018825
Filing Date
2024-02-22
Accepted
2024-02-22 16:34:23
Documents
6
Effectiveness Date
2024-02-22

Document Format Files

Seq Description Document Type Size
1 S-8 atha_february_2024_s-8.htm S-8 235024
2 EX-5.1 atha-ex5_1.htm EX-5.1 11332
3 EX-23.1 atha-ex23_1.htm EX-23.1 3616
4 EX-FILING FEES atha-exfiling_fees.htm EX-FILING FEES 43763
5 GRAPHIC img222338278_0.jpg GRAPHIC 10051
6 GRAPHIC img222338278_1.jpg GRAPHIC 125859
  Complete submission text file 0000950170-24-018825.txt   482206
Mailing Address 18706 NORTH CREEK PARKWAY, SUITE 104 BOTHELL WA 98011
Business Address 18706 NORTH CREEK PARKWAY, SUITE 104 BOTHELL WA 98011 (425) 620-8501
Athira Pharma, Inc. (Filer) CIK: 0001620463 (see all company filings)

EIN.: 453368487 | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-277276 | Film No.: 24665416
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)